resveratrol has been researched along with Atherogenesis in 71 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (16.90) | 29.6817 |
| 2010's | 43 (60.56) | 24.3611 |
| 2020's | 16 (22.54) | 2.80 |
| Authors | Studies |
|---|---|
| Katselou, MG; Kourounakis, AP; Matralis, AN | 1 |
| Chen, Y; Feng, F; Li, Q; Liu, W; Liu, Y; Sun, H; Xing, S | 1 |
| Alves de Castro, I; Barroso, LP; Ogawa, LY; Rogero, MM; Santana, TM | 1 |
| Netticadan, T; Raj, P; Thandapilly, SJ; Wigle, J; Zieroth, S | 1 |
| Anandh Babu, PV; Jia, Z; Kang, ZY; Liu, D; Nallasamy, P; Sun, X | 1 |
| Haiyun, Z; Lixia, G; Xia, Z | 1 |
| Fang, Y; Yu, GH | 1 |
| Guo, S; Xie, X; Zhou, Y | 1 |
| Li, H; Li, Y; Su, M; Weng, J; Xu, S; Zhao, W | 1 |
| Esteghamati, A; Mohammadi, F; Mosavi, SS; Nakhjavani, M; Qahremani, R; Rabizadeh, S; Rajab, A; Salehi, SS; Seifouri, S; Yadegar, A | 1 |
| Cheng, W; Cheng, X; Hu, T; Jing, Y; Liu, Z; Ou, M; Tao, M; Xiong, Q; Yi, Y; Yuan, J | 1 |
| Aparna, NS; Aswani, SS; Boban, PT; Mohan, MS; Saja, K | 1 |
| Assefa, EG; Gezahegn, SB; He, S; Salissou, MTM; Wu, N; Yan, Q; Ying, C; Zuo, X | 1 |
| Almutairi, MM; Hong, M; Li, J; Li, S | 1 |
| Atanasov, AG; Horbańczuk, J; Huminiecki, L | 1 |
| Hisatome, T; Miyazaki, H; Nakamoto, Y; Wu, CW; Yoshida, S | 1 |
| Cebova, M; Dayar, E; Pechanova, O | 1 |
| Chen, W; Feng, X; Li, L; Xu, S; Zhang, L; Zhang, S | 1 |
| Imamura, H; Nagayama, D; Saiki, A; Shirai, K; Tatsuno, I; Yamaguchi, T | 1 |
| Chen, G; Dong, S; Fan, Y; Guo, Q; Liu, J; Liu, X; Tu, Y; Wang, L; Wang, Z; Ye, G; Ye, Z; Zhang, X | 1 |
| Abdalla, DSP; Castro, IA; Cavalcanti, MF; Chassot, LN; Cogliati, B; Roschel, GG; Scolaro, B | 1 |
| Choi, W; Go, YM; Ju Son, D; Kim, MK; Park, H; Park, J; Pyee, J; Seo, Y; Sung Kim, Y; Tae Hong, J; Yoon, BE | 1 |
| Chen, X; Huang, Z; Li, J; Wu, Z; Yuan, J; Zhong, Z | 1 |
| Chen, G; Chi, Y; Dong, S; Fan, Y; Gao, H; Huang, Q; Liao, X; Lin, Y; Liu, X; Ye, G; Zhang, H; Zhu, H | 1 |
| Hajizadeh-Sharafabad, F; Maleki, V; Sahebkar, A; Zabetian-Targhi, F | 1 |
| Chen, Y; Hou, X; Shi, Y; Wang, Y; Zhang, X; Zou, J | 1 |
| Dou, JL; Guo, JZ; Hu, YJ; Li, L; Li, WQ; Lu, D; Song, R; Sun, L; Zhang, G | 1 |
| Guo, R; Li, S; Liu, B; Xu, Y; Zhang, B | 1 |
| Dash, S; Lewis, GF; Morgantini, C; Xiao, C | 1 |
| Koh, KK; Lim, S; Quon, MJ | 1 |
| Abaci, HE; Gerecht, S; Shen, YI; Tan, S | 1 |
| Businaro, R; Buttari, B; D'Arcangelo, D; Facchiano, F; Iuliano, L; Profumo, E; Riganò, R; Rossi, S; Saso, L; Segoni, L | 1 |
| Antonopoulou, S; Asimakopoulos, D; Demopoulos, CA; Fragopoulou, E; Xanthopoulou, MN | 1 |
| Chen, SL; Gao, X; Li, B; Liu, Y; Mao, W; Wang, Z; Zhang, J | 1 |
| Deng, ZY; Gang, C; Hu, MM; Xin, YF | 1 |
| Chen, ML; Mi, MT; Ran, L; Yang, J; Yi, L; Zhang, QY; Zhang, Y; Zhou, X; Zhu, JD | 1 |
| Gollavilli, PN; Gopoju, R; Karnewar, S; Kotamraju, S; Kumar, JM; Narra, SR; Vasamsetti, SB | 1 |
| Carsons, SE; DeLeon, J; Fazzari, MJ; Littlefield, MJ; Reiss, AB; Siegart, NM; Teboul, I; Turi, GK; Voloshyna, I | 1 |
| Choi, MS; Do, GM; Ha, TY; Jeon, SM; Kim, HJ; Kwon, EY; Park, T | 1 |
| Andriantsitohaina, R; Lagrue-Lak-Hal, AH | 1 |
| Bai, Y; Fan, E; Jiang, S; Zhang, L | 1 |
| Almeida, LM; Augé, N; Brito, PM; Devillard, R; Dinis, TC; Nègre-Salvayre, A; Salvayre, R | 1 |
| Cataneo, AC; Ebaid, GX; Novelli, EL; Rocha, KK; Seiva, FR; Souza, GA | 1 |
| Beronov, K; Cicha, I; Daniel, WG; Garlichs, CD; Goppelt-Struebe, M; Osterode, K; Raaz, D; Ramirez, EL; Yilmaz, A | 1 |
| Berrougui, H; Drouin, G; Grenier, G; Khalil, A; Loued, S | 1 |
| Chandrasekar, B; Reddy, VS; Siwik, DA; Valente, AJ; Venkatesan, B | 1 |
| Avogaro, A; Bortoluzzi, A; Ceolotto, G; Cobelli, C; Dalla Man, C; de Kreutzenberg, SV; Fadini, GP; Papparella, I; Semplicini, A | 1 |
| Luo, Z; Ma, L; Si, L; Xu, Q; Yang, Q; Zhang, Y | 1 |
| Favaloro, EJ; Franchini, M; Lippi, G; Targher, G | 1 |
| Jones, PJ; Ramprasath, VR | 1 |
| Csiszar, A; de Cabo, R; Kaley, G; Sonntag, WE; Ungvari, Z | 1 |
| Cerletti, C; de Gaetano, G; Gresele, P; Guglielmini, G; Pignatelli, P; Violi, F | 1 |
| Kleemann, R; Kooistra, T; Tijani, S; Toet, K; van Duyvenvoorde, W; van Ommen, B; Verschuren, L; Wielinga, PY | 1 |
| Araki, M; Ghorbel, A; Kusunoki, M; Miyazaki, H; Mliki, A; Yoshida, S; Zghonda, N | 1 |
| Asmis, R; Ullevig, SL; Zamora, D; Zhao, Q | 1 |
| Feng, P; Wang, N; Yang, J; Zhu, Y | 1 |
| Bruedigam, C; Chiba, H; Eijken, M; Koedam, M; van Leeuwen, JP | 1 |
| Azorín-Ortuño, M; Espín, JC; García-Conesa, MT; González-Sarrías, A; Larrosa, M; Lucas, R; Morales, JC; Pallarés, FJ; Tomás-Barberán, FA; Vallejo, F; Yáñez-Gascón, MJ | 1 |
| Baroncini, LA; Caron, EY; Kaiber, F; Lambach, PH; Matos, RS; Précoma, DB; Précoma, LB; Winter, G | 1 |
| Houston, M | 1 |
| Burdan, F; Fraczek, M; Podlodowska, J; Szumiło, J | 1 |
| Azorín-Ortuño, M; Espín, JC; García-Conesa, MT; González-Sarrías, A; Larrosa, M; Pallarés, FJ; Rivera, J; Tomás-Barberán, F; Vallejo, F; Yañéz-Gascón, MJ | 1 |
| Hussaini, SM; Reiss, AB; Voloshyna, I | 1 |
| Carsons, S; Hai, O; Littlefield, MJ; Reiss, AB; Voloshyna, I | 1 |
| Agarwal, B; Baur, JA; Campen, MJ; Channell, MM; Davis, JG; Smoliga, JM; Varamini, B; Wherry, SJ | 1 |
| Allen, AM; Graham, A | 1 |
| Berbée, JF; Havekes, LM; Hiemstra, PS; Khedoe, PP; Mol, IM; Princen, HM; Rensen, PC; Romijn, JA; Tsikas, D; van der Hoorn, JW; van Klinken, JB; Wang, Y; Wong, MC | 1 |
| Dulak, J | 1 |
| Cao, K; Hsieh, TC; Huang, Y; Wang, Z; Wu, JM; Zou, J | 1 |
| Cohen, RA; Hou, X; Jiang, B; Maitland-Toolan, KA; Verbeuren, TJ; Wierzbicki, M; Xu, S; Zang, M; Zuccollo, A | 1 |
| Moreno, JJ; Vivancos, M | 1 |
18 review(s) available for resveratrol and Atherogenesis
| Article | Year |
|---|---|
Effect of resveratrol supplementation on biomarkers associated with atherosclerosis in humans.
Topics: Antioxidants; Atherosclerosis; Biomarkers; Dietary Supplements; Humans; Resveratrol | 2022 |
A Comprehensive Analysis of the Efficacy of Resveratrol in Atherosclerotic Cardiovascular Disease, Myocardial Infarction and Heart Failure.
Topics: Animals; Atherosclerosis; Cardiovascular Diseases; Heart Failure; Humans; Myocardial Infarction; Resveratrol | 2021 |
Resveratrol inhibiting TGF/ERK signaling pathway can improve atherosclerosis: backgrounds, mechanisms and effects.
Topics: Atherosclerosis; Extracellular Signal-Regulated MAP Kinases; Humans; Resveratrol; Signal Transduction; Transforming Growth Factor beta; Transforming Growth Factors | 2022 |
Etiology of atherosclerosis informs choice of animal models and tissues for initial functional genomic studies of resveratrol.
Topics: Animals; Atherosclerosis; Diet; Dietary Supplements; Disease Models, Animal; Female; Gene Expression Profiling; Gene Regulatory Networks; Genomics; Humans; Leukocytes, Mononuclear; Liver; Male; Muscle, Skeletal; Oligonucleotide Array Sequence Analysis; Resveratrol; Species Specificity; Transcriptome | 2020 |
Therapeutic Potential of Polyphenols-Loaded Polymeric Nanoparticles in Cardiovascular System.
Topics: Animals; Antioxidants; Atherosclerosis; Biological Availability; Biological Products; Cardiovascular System; Curcumin; Drug Compounding; Heart Failure; Humans; Hypertension; Nanocapsules; Nitric Oxide; Nitric Oxide Synthase Type III; Polymers; Polyphenols; Quercetin; Reactive Oxygen Species; Resveratrol | 2020 |
Natural products: The role and mechanism in low-density lipoprotein oxidation and atherosclerosis.
Topics: Abietanes; Antioxidants; Atherosclerosis; Biological Products; Catechin; Dietary Supplements; Humans; Lipoproteins, LDL; Lycopene; Phytotherapy; Plant Extracts; Probucol; Quercetin; Resveratrol; Vitamin E | 2021 |
The impact of resveratrol on toxicity and related complications of advanced glycation end products: A systematic review.
Topics: Animals; Antigens, Neoplasm; Antioxidants; Atherosclerosis; Diabetes Mellitus, Experimental; Gene Expression Regulation; Glycation End Products, Advanced; Humans; Inflammation; Mitogen-Activated Protein Kinases; NF-kappa B; Oxidative Stress; PPAR gamma; Pyruvaldehyde; Resveratrol; Signal Transduction; Transforming Growth Factor beta1 | 2019 |
New and emerging regulators of intestinal lipoprotein secretion.
Topics: Animals; Apolipoprotein B-100; Apolipoprotein B-48; Atherosclerosis; Bile Acids and Salts; Cholesterol; Chylomicrons; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Dietary Fats; Dipeptidyl-Peptidase IV Inhibitors; Drug Evaluation, Preclinical; Dyslipidemias; Exenatide; Fatty Acids, Nonesterified; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glucagon-Like Peptide-1 Receptor; Humans; Incretins; Insulin; Insulin Resistance; Intestine, Small; Lipoproteins; Microbiota; Peptides; Receptors, Glucagon; Resveratrol; Secretory Rate; Stilbenes; Triglycerides; Venoms | 2014 |
Modulation of adiponectin as a potential therapeutic strategy.
Topics: Adiponectin; Antihypertensive Agents; Atherosclerosis; Bariatric Surgery; Cardiovascular Diseases; Clinical Trials as Topic; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Reducing; Exercise; Humans; Hypoglycemic Agents; Insulin Resistance; Life Style; Metabolic Syndrome; Metabolism, Inborn Errors; Obesity; Peroxisome Proliferator-Activated Receptors; Receptors, Adiponectin; Resveratrol; Stilbenes | 2014 |
Red wine and cardiovascular risks.
Topics: Alcohol Drinking; Animals; Aorta; Atherosclerosis; Cardiovascular Diseases; Color; Endothelium, Vascular; Flavonoids; Humans; Models, Animal; Phenols; Polyphenols; Resveratrol; Risk Assessment; Stilbenes; Thrombosis; Vascular Diseases; Vasodilator Agents; Wine | 2006 |
Beneficial effects of resveratrol on atherosclerosis.
Topics: Antioxidants; Atherosclerosis; Cholesterol, LDL; Humans; Inflammation; Oxidative Stress; Phytotherapy; Platelet Aggregation; Reactive Oxygen Species; Resveratrol; Stilbenes; Vasodilator Agents; Vitis | 2008 |
Moderate red wine consumption and cardiovascular disease risk: beyond the "French paradox".
Topics: Alcohol Drinking; Antioxidants; Atherosclerosis; Blood Pressure; Cardiovascular Diseases; Cholesterol, HDL; Coronary Artery Disease; Endothelium, Vascular; Fibrinolysis; Hemostasis; Humans; Resveratrol; Stilbenes; Wine | 2010 |
Anti-atherogenic effects of resveratrol.
Topics: Animals; Antioxidants; Atherosclerosis; Cardiovascular Diseases; Humans; Lipids; Phytotherapy; Plant Extracts; Resveratrol; Stilbenes; Vitis | 2010 |
Mechanisms of vascular aging: new perspectives.
Topics: Aging; Animals; Apoptosis; Atherosclerosis; Blood Vessels; Caloric Restriction; Endothelium, Vascular; Exercise; Humans; Inflammation; Oxidative Stress; Resveratrol; Stem Cells; Stilbenes; Vascular Diseases | 2010 |
Effects of resveratrol and other wine polyphenols on vascular function: an update.
Topics: Antioxidants; Atherosclerosis; Blood Platelets; Cell Adhesion Molecules; Endothelium, Vascular; Flavonoids; Humans; Nitric Oxide; Oxidative Stress; Phenols; Polyphenols; Reactive Oxygen Species; Resveratrol; Stilbenes; Wine | 2011 |
[Resveratrol--phytophenol with wide activity].
Topics: Adipose Tissue; Animals; Anti-Inflammatory Agents; Atherosclerosis; Cardiovascular Diseases; Chemoprevention; Glucose; Humans; Longevity; Neoplasms; Neurodegenerative Diseases; Resveratrol; Stilbenes | 2012 |
Resveratrol in cholesterol metabolism and atherosclerosis.
Topics: Angiogenesis Modulating Agents; Animals; Antioxidants; Atherosclerosis; Cardiotonic Agents; Cholesterol; Dietary Supplements; Humans; Resveratrol; Stilbenes; Vasodilator Agents | 2012 |
Nutraceuticals as anti-angiogenic agents: hopes and reality.
Topics: Angiogenesis Inhibitors; Animals; Atherosclerosis; Catechin; Curcumin; Dietary Supplements; Flavonoids; Humans; Neoplasms; Neovascularization, Pathologic; Phenols; Polyphenols; Resveratrol; Stilbenes; Vascular Endothelial Growth Factor A | 2005 |
2 trial(s) available for resveratrol and Atherogenesis
| Article | Year |
|---|---|
Resveratrol Ameliorates Arterial Stiffness Assessed by Cardio-Ankle Vascular Index in Patients With Type 2 Diabetes Mellitus.
Topics: Administration, Oral; Ankle Brachial Index; Antioxidants; Atherosclerosis; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Oxidative Stress; Resveratrol; Retrospective Studies; Stilbenes; Treatment Outcome; Vascular Stiffness | 2017 |
Resveratrol for primary prevention of atherosclerosis: clinical trial evidence for improved gene expression in vascular endothelium.
Topics: Atherosclerosis; Double-Blind Method; Endothelium, Vascular; Female; Gene Expression Regulation; Humans; Male; Resveratrol; Stilbenes | 2013 |
51 other study(ies) available for resveratrol and Atherogenesis
| Article | Year |
|---|---|
Developing potential agents against atherosclerosis: Design, synthesis and pharmacological evaluation of novel dual inhibitors of oxidative stress and Squalene Synthase activity.
Topics: Animals; Atherosclerosis; Cyclooxygenase 1; Cyclooxygenase 2; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Farnesyl-Diphosphate Farnesyltransferase; Humans; Hypolipidemic Agents; Male; Mice; Mice, Hairless; Molecular Structure; Morpholines; Oxidative Stress; Rats; Structure-Activity Relationship; Thiazines | 2017 |
p62/SQSTM1, a Central but Unexploited Target: Advances in Its Physiological/Pathogenic Functions and Small Molecular Modulators.
Topics: Animals; Atherosclerosis; Autophagy; Humans; Neurodegenerative Diseases; Osteitis Deformans; Protein Domains; Sequestosome-1 Protein; Signal Transduction; Tumor Suppressor Proteins | 2020 |
Natural Compound Resveratrol Attenuates TNF-Alpha-Induced Vascular Dysfunction in Mice and Human Endothelial Cells: The Involvement of the NF-κB Signaling Pathway.
Topics: Animals; Aorta; Atherosclerosis; Biological Products; Cell Adhesion; Chemokine CCL2; Endothelial Cells; Gene Expression Regulation; Humans; Intercellular Adhesion Molecule-1; Mice; Monocytes; NF-kappa B; Resveratrol; Signal Transduction; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1; Vascular Diseases | 2021 |
The clinical effects of resveratrol on atherosclerosis treatment and its effect on the expression of NADPH oxidase complex genes in vascular smooth muscle cell line.
Topics: Antioxidants; Atherosclerosis; Blood Pressure; Cell Line; Cholesterol; Gene Expression Regulation; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Middle Aged; Muscle, Smooth, Vascular; NADPH Oxidases; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Triglycerides | 2021 |
Resveratrol attenuates atherosclerotic endothelial injury through the Pin1/Notch1 pathway.
Topics: Animals; Atherosclerosis; Endothelium; Human Umbilical Vein Endothelial Cells; Humans; Lipoproteins, LDL; Mice; NIMA-Interacting Peptidylprolyl Isomerase; Receptor, Notch1; Resveratrol; RNA, Messenger; Selectins; von Willebrand Factor | 2022 |
Genome-Wide Transcriptional Profiling Reveals PHACTR1 as a Novel Molecular Target of Resveratrol in Endothelial Homeostasis.
Topics: Atherosclerosis; Cardiovascular Diseases; Homeostasis; Human Umbilical Vein Endothelial Cells; Humans; Resveratrol | 2022 |
Therapeutic effects of resveratrol and Omega-3 in mice atherosclerosis: focus on histopathological changes.
Topics: Animals; Aorta; Atherosclerosis; Diet, Atherogenic; Fatty Acids, Omega-3; Male; Mice; Mice, Inbred C57BL; Resveratrol | 2023 |
Resveratrol protects against postmenopausal atherosclerosis progression through reducing PCSK9 expression via the regulation of the ERα-mediated signaling pathway.
Topics: Animals; Atherosclerosis; Estrogen Receptor alpha; Mice; Mice, Knockout, ApoE; Postmenopause; Proprotein Convertase 9; Proprotein Convertases; Receptors, LDL; Resveratrol; Signal Transduction; Subtilisin | 2023 |
Oxidized LDL-mediated upregulation of ADAMTS-4 in monocytes/macrophages involves ROS-NF-κB-SIRT-1 pathway.
Topics: ADAMTS4 Protein; Atherosclerosis; Humans; Leukocytes, Mononuclear; Macrophages; Monocytes; NF-kappa B; Reactive Oxygen Species; Resveratrol; RNA, Messenger; Up-Regulation | 2023 |
Role of Resveratrol on Indoxyl Sulfate-Induced Endothelial Hyperpermeability via Aryl Hydrocarbon Receptor (AHR)/Src-Dependent Pathway.
Topics: Animals; Antigens, CD; Antioxidants; Aorta; Atherosclerosis; Cadherins; Cattle; Cell Membrane Permeability; Cells, Cultured; Electric Impedance; Endothelial Cells; Indican; Oxidative Stress; Receptors, Aryl Hydrocarbon; Renal Insufficiency, Chronic; Resveratrol; Signal Transduction; src-Family Kinases | 2019 |
Resveratrol Derivative, Trans-3, 5, 4'-Trimethoxystilbene, Prevents the Developing of Atherosclerotic Lesions and Attenuates Cholesterol Accumulation in Macrophage Foam Cells.
Topics: Animals; Atherosclerosis; ATP Binding Cassette Transporter 1; Cholesterol; Foam Cells; Heme Oxygenase-1; Humans; Lipoproteins, LDL; Male; Mice, Inbred C57BL; Mice, Knockout, ApoE; NF-E2-Related Factor 2; Resveratrol; Scavenger Receptors, Class A; Stilbenes; Triggering Receptor Expressed on Myeloid Cells-1 | 2020 |
Resveratrol and its dimers ε-viniferin and δ-viniferin in red wine protect vascular endothelial cells by a similar mechanism with different potency and efficacy.
Topics: Animals; Antioxidants; Atherosclerosis; Benzofurans; Carbazoles; Catalase; Cell Line; Cell Survival; Dimerization; Endothelial Cells; Enzyme Inhibitors; Gene Expression Regulation; Heme Oxygenase-1; Humans; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Protoporphyrins; Resorcinols; Resveratrol; Sirtuin 1; Stilbenes; Swine; Wine | 2020 |
Metabolomics Reveals Protection of Resveratrol in Diet-Induced Metabolic Risk Factors in Abdominal Muscle.
Topics: Abdominal Muscles; Amino Acids; Animals; Apolipoproteins E; Atherosclerosis; Carbohydrate Metabolism; Diet, High-Fat; Discriminant Analysis; Gas Chromatography-Mass Spectrometry; Least-Squares Analysis; Lipid Metabolism; Lipids; Metabolic Diseases; Mice; Mice, Knockout; Microscopy, Electron; Monosaccharides; Resveratrol; Risk Factors; Stilbenes | 2018 |
Comparison between red wine and isolated trans-resveratrol on the prevention and regression of atherosclerosis in LDLr
Topics: Animals; Atherosclerosis; Body Weight; Dietary Supplements; Disease Models, Animal; Fatty Acids; Liver; Male; Mice, Knockout; Oxidative Stress; Receptors, LDL; Resveratrol; Wine | 2018 |
Antiatherogenic Effect of Resveratrol Attributed to Decreased Expression of ICAM-1 (Intercellular Adhesion Molecule-1).
Topics: Active Transport, Cell Nucleus; Animals; Atherosclerosis; Carotid Arteries; Carotid Stenosis; Cell Adhesion; Disease Models, Animal; Down-Regulation; Endothelium, Vascular; Enzyme Induction; Focal Adhesion Kinase 1; Inflammation; Lactoferrin; Ligation; Mice; Mice, Knockout, ApoE; Monocytes; NF-E2-Related Factor 2; Random Allocation; Resveratrol; Transcription, Genetic | 2019 |
Resveratrol improves endothelial dysfunction and attenuates atherogenesis in apolipoprotein E-deficient mice.
Topics: Animals; Atherosclerosis; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Endothelial Cells; Endothelium, Vascular; Humans; Male; Mice, Knockout, ApoE; Nitric Oxide Synthase Type III; Oxidative Stress; Resveratrol; Serine; Vasodilation | 2019 |
Resveratrol inhibits lipid accumulation in the intestine of atherosclerotic mice and macrophages.
Topics: Animals; Antioxidants; Atherosclerosis; Cholesterol; Intestines; Lipid Metabolism; Macrophages; Male; Metabolome; Mice; Mice, Knockout, ApoE; PPAR alpha; PPAR gamma; Resveratrol | 2019 |
Inhibition of oxidized-phospholipid-induced vascular smooth muscle cell proliferation by resveratrol is associated with reducing Cx43 phosphorylation.
Topics: Animals; Aorta; Atherosclerosis; Cell Cycle; Cell Line; Cell Proliferation; Cells, Cultured; Connexin 43; Down-Regulation; Humans; Myocytes, Smooth Muscle; Oxidation-Reduction; Phospholipids; Phosphorylation; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2013 |
[Resveratrol reduces inflammatory cytokines via inhibiting nuclear factor-κB and mitogen-activated protein kinase signal pathway in a rabbit atherosclerosis model].
Topics: Animals; Atherosclerosis; Disease Models, Animal; Interleukin-1beta; Interleukin-6; Male; Mitogen-Activated Protein Kinases; NF-kappa B; Phosphorylation; Rabbits; Resveratrol; Signal Transduction; Stilbenes; Tumor Necrosis Factor-alpha | 2013 |
Enhancement in efferocytosis of oxidized low-density lipoprotein-induced apoptotic RAW264.7 cells through Sirt1-mediated autophagy.
Topics: Apoptosis; Atherosclerosis; Autophagy; Cell Line; Gene Expression Regulation; Humans; Lipoproteins, LDL; Molecular Targeted Therapy; Resveratrol; Sirtuin 1; Stilbenes | 2014 |
Recapitulating physiological and pathological shear stress and oxygen to model vasculature in health and disease.
Topics: Animals; Atherosclerosis; Capillary Permeability; Endothelial Cells; Endothelium, Vascular; Fluorouracil; Humans; Ischemia; Mice; Microfluidic Analytical Techniques; Oxygen Consumption; Resveratrol; Stilbenes; Stress, Mechanical; Vascular Diseases | 2014 |
Resveratrol counteracts inflammation in human M1 and M2 macrophages upon challenge with 7-oxo-cholesterol: potential therapeutic implications in atherosclerosis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Atherosclerosis; Cells, Cultured; Chemokines; Cytokines; Down-Regulation; Endocytosis; Humans; Inflammation; Intercellular Signaling Peptides and Proteins; Ketocholesterols; Lipopolysaccharide Receptors; Macrophages; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Monocytes; NF-kappa B; Receptors, IgG; Resveratrol; Stilbenes; Up-Regulation | 2014 |
Effect of Robola and Cabernet Sauvignon extracts on platelet activating factor enzymes activity on U937 cells.
Topics: Atherosclerosis; Humans; Platelet Activating Factor; Resveratrol; Stilbenes; U937 Cells; Wine | 2014 |
Resveratrol ameliorates low shear stress‑induced oxidative stress by suppressing ERK/eNOS‑Thr495 in endothelial cells.
Topics: Antioxidants; Atherosclerosis; Cell Survival; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Human Umbilical Vein Endothelial Cells; Humans; L-Lactate Dehydrogenase; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Reactive Oxygen Species; Resveratrol; RNA, Messenger; Shear Strength; Stilbenes; Threonine | 2014 |
Resveratrol alleviates vascular inflammatory injury by inhibiting inflammasome activation in rats with hypercholesterolemia and vitamin D2 treatment.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aorta, Thoracic; Atherosclerosis; Carrier Proteins; Caspase 1; Ergocalciferols; Hypercholesterolemia; Inflammasomes; Inflammation; Lipid Peroxidation; Lipids; Male; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Vitamins | 2015 |
Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.
Topics: Animals; Atherosclerosis; Bacteria; Bile Acids and Salts; Cholesterol 7-alpha-Hydroxylase; Female; Gastrointestinal Microbiome; Humans; Liver; Methylamines; Mice; Mice, Inbred C57BL; Resveratrol; Stilbenes | 2016 |
Resveratrol attenuates monocyte-to-macrophage differentiation and associated inflammation via modulation of intracellular GSH homeostasis: Relevance in atherosclerosis.
Topics: Acetylcysteine; AMP-Activated Protein Kinases; Animals; Antioxidants; Apolipoproteins E; Atherosclerosis; Buthionine Sulfoximine; Cell Differentiation; Glutathione; Homeostasis; Humans; Inflammation; Macrophages; Matrix Metalloproteinase 9; Mice; Mice, Knockout; Monocytes; Resveratrol; Stilbenes; Tetradecanoylphorbol Acetate | 2016 |
Resveratrol counters systemic lupus erythematosus-associated atherogenicity by normalizing cholesterol efflux.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Cholesterol; fas Receptor; Humans; Lupus Erythematosus, Systemic; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Resveratrol; Stilbenes | 2016 |
Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice.
Topics: Acetyl-CoA C-Acetyltransferase; Animals; Antioxidants; Aorta; Apolipoproteins E; Aryldialkylphosphatase; Atherosclerosis; Cholesterol; Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent; Lipid Peroxidation; Liver; Male; Mice; Mice, Mutant Strains; Resveratrol; Stilbenes; Thiobarbituric Acid Reactive Substances | 2008 |
Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells.
Topics: Angiogenesis Inhibitors; Animals; Antioxidants; Atherosclerosis; Cell Proliferation; Flavonoids; Humans; Lipoproteins, LDL; Myocytes, Smooth Muscle; Phenols; Phosphatidylinositol 3-Kinases; Polyphenols; Protein Kinases; Rabbits; Resveratrol; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Stilbenes; TOR Serine-Threonine Kinases | 2009 |
Resveratrol toxicity: effects on risk factors for atherosclerosis and hepatic oxidative stress in standard and high-fat diets.
Topics: Animals; Antioxidants; Atherosclerosis; Blood Glucose; Body Weight; Diet; Dietary Fats; Dietary Supplements; Glutathione; Lipid Peroxides; Lipids; Lipoproteins, LDL; Liver; Male; Organ Size; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Risk Factors; Stilbenes; Triglycerides; Wine | 2009 |
Shear stress preconditioning modulates endothelial susceptibility to circulating TNF-alpha and monocytic cell recruitment in a simplified model of arterial bifurcations.
Topics: Anti-Inflammatory Agents; Atherosclerosis; Cell Adhesion; Cell Culture Techniques; Cells, Cultured; Computer Simulation; E-Selectin; Endothelial Cells; Fluorescent Antibody Technique; Humans; Models, Cardiovascular; Monocytes; NF-kappa B; Numerical Analysis, Computer-Assisted; Resveratrol; Simvastatin; Stilbenes; Stress, Mechanical; Stress, Physiological; Time Factors; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2009 |
A new insight into resveratrol as an atheroprotective compound: inhibition of lipid peroxidation and enhancement of cholesterol efflux.
Topics: Animals; Apolipoprotein A-I; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Cholesterol; Dose-Response Relationship, Drug; Free Radical Scavengers; Humans; Kinetics; Linear Models; Lipid Peroxidation; Lipoproteins, HDL; Lipoproteins, LDL; Macrophages; Mice; Oxidation-Reduction; Resveratrol; Stilbenes | 2009 |
Resveratrol blocks interleukin-18-EMMPRIN cross-regulation and smooth muscle cell migration.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aorta; Atherosclerosis; Basigin; Cell Movement; Cells, Cultured; Cross-Linking Reagents; Extracellular Signal-Regulated MAP Kinases; Humans; Interleukin-18; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Resveratrol; RNA, Small Interfering; Signal Transduction; Stilbenes; Vasculitis | 2009 |
Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms.
Topics: Angiogenesis Inhibitors; Atherosclerosis; Carotid Arteries; Down-Regulation; Glucose; Glucose Tolerance Test; Humans; Insulin Resistance; Longevity; Metabolic Syndrome; Monocytes; Palmitic Acid; Reference Values; Resveratrol; Sirtuin 1; Stilbenes; Tunica Intima; Tunica Media | 2010 |
Resveratrol prevents the impairment of advanced glycosylation end products (AGE) on macrophage lipid homeostasis by suppressing the receptor for AGE via peroxisome proliferator-activated receptor gamma activation.
Topics: Adenylate Kinase; Animals; Antioxidants; Atherosclerosis; Cholesterol; Diabetes Complications; Diabetes Mellitus; Glycation End Products, Advanced; Homeostasis; Humans; Lipid Metabolism; Macrophages; PPAR gamma; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Resveratrol; Stilbenes | 2010 |
A dietary mixture containing fish oil, resveratrol, lycopene, catechins, and vitamins E and C reduces atherosclerosis in transgenic mice.
Topics: Acute-Phase Proteins; Animals; Antioxidants; Apolipoprotein E3; Ascorbic Acid; Atherosclerosis; Biomarkers; C-Reactive Protein; Carotenoids; Catechin; Diet; Female; Fish Oils; Humans; Lycopene; Male; Mice; Mice, Transgenic; Resveratrol; Risk Factors; Stilbenes; Vitamin E | 2011 |
Greater effectiveness of ε-viniferin in red wine than its monomer resveratrol for inhibiting vascular smooth muscle cell proliferation and migration.
Topics: Animals; Atherosclerosis; Benzofurans; Cell Movement; Cell Proliferation; Cells, Cultured; Extracellular Signal-Regulated MAP Kinases; Heme Oxygenase-1; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Stilbenes; Wine | 2011 |
Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis.
Topics: Animals; Aortic Diseases; Atherosclerosis; Cardiovascular Agents; Cell Line; Chemokine CCL2; Chemotaxis, Leukocyte; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dose-Response Relationship, Drug; Female; Humans; Hyperlipidemias; Kidney; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Oxidative Stress; Receptors, CCR2; Receptors, LDL; Resveratrol; Stilbenes; Time Factors; Triterpenes; Ursolic Acid | 2011 |
Roles of SIRT1 in high glucose-induced endothelial impairment: association with diabetic atherosclerosis.
Topics: Atherosclerosis; Base Sequence; Cells, Cultured; Diabetic Angiopathies; DNA Primers; Endothelium, Vascular; Glucose; Humans; Nitric Oxide; Real-Time Polymerase Chain Reaction; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Sirtuin 1; Stilbenes | 2011 |
Opposing actions of rosiglitazone and resveratrol on mineralization in human vascular smooth muscle cells.
Topics: Apoptosis; Atherosclerosis; Caspases; Cell Differentiation; Cells, Cultured; Diabetes Mellitus; Humans; Hypoglycemic Agents; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxidative Stress; Resveratrol; Rosiglitazone; Signal Transduction; Stilbenes; Thiazolidinediones; Up-Regulation | 2011 |
Effects of long-term consumption of low doses of resveratrol on diet-induced mild hypercholesterolemia in pigs: a transcriptomic approach to disease prevention.
Topics: Animals; Atherosclerosis; Cholesterol; Diet, High-Fat; Dietary Fats; Dose-Response Relationship, Drug; Down-Regulation; Fatty Acid-Binding Proteins; Female; Hypercholesterolemia; Leukocytes, Mononuclear; Lipid Metabolism; Lipoprotein Lipase; Lipoproteins, LDL; Male; Microarray Analysis; Resveratrol; Stilbenes; Swine; Transcriptome; Up-Regulation | 2012 |
Resveratrol causes antiatherogenic effects in an animal model of atherosclerosis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Atherosclerosis; Cholesterol, Dietary; Disease Models, Animal; Drug Evaluation, Preclinical; Hypercholesterolemia; Male; Platelet Aggregation Inhibitors; Rabbits; Random Allocation; Resveratrol; Statistics, Nonparametric; Stilbenes | 2012 |
The role of nutraceutical supplements in the treatment of dyslipidemia.
Topics: Atherosclerosis; Dietary Fats; Dietary Supplements; Dyslipidemias; Humans; Lipoproteins; Lipoproteins, VLDL; Oxidative Stress; Pantetheine; Resveratrol; Stilbenes; Tocotrienols; Triglycerides; Vascular Diseases; Vasodilator Agents | 2012 |
A dietary resveratrol-rich grape extract prevents the developing of atherosclerotic lesions in the aorta of pigs fed an atherogenic diet.
Topics: Animals; Aorta; Atherosclerosis; Diet, Atherogenic; Disease Models, Animal; Female; Humans; In Vitro Techniques; Male; Plant Extracts; Resveratrol; Stilbenes; Swine; Swine, Miniature; Vitis | 2012 |
Resveratrol mediates anti-atherogenic effects on cholesterol flux in human macrophages and endothelium via PPARγ and adenosine.
Topics: Adenosine; Animals; Apolipoprotein A-I; Atherosclerosis; Biological Transport; CD36 Antigens; Cell Line; Cholesterol; Endothelium; Foam Cells; Gene Expression Regulation; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Macrophages; Monocytes; PPAR gamma; Receptors, Adenosine A2; Resveratrol; Stilbenes | 2013 |
Mitochondrial function is involved in regulation of cholesterol efflux to apolipoprotein (apo)A-I from murine RAW 264.7 macrophages.
Topics: Animals; Antimycin A; Apolipoproteins A; Atherosclerosis; Cell Line; Cell Survival; Cholesterol; Cholesterol Esters; DNA, Mitochondrial; Macrophages; Membrane Potential, Mitochondrial; Mice; Mitochondria; Nigericin; Oligomycins; Reactive Oxygen Species; Resveratrol; RNA, Messenger; Stilbenes | 2012 |
Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice.
Topics: Animals; Atherosclerosis; Atorvastatin; Biomarkers; Cholesterol, Dietary; Cholesterol, LDL; Drug Synergism; Female; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Mice; Mice, Transgenic; Oxidative Stress; Pyrroles; Resveratrol; Stilbenes | 2013 |
Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels.
Topics: Analysis of Variance; Animals; Aorta, Thoracic; Atherosclerosis; Body Weight; Cholesterol, Dietary; Dose-Response Relationship, Drug; Ethanol; Femoral Artery; Hypercholesterolemia; Lipids; Male; Rabbits; Resveratrol; Stilbenes; Vasodilation; Vasodilator Agents; Wine | 2005 |
Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice.
Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Apigenin; Atherosclerosis; Benzopyrans; Carcinoma, Hepatocellular; Cell Line, Tumor; Diabetes Mellitus, Experimental; Enzyme Activation; Flavonoids; Glucose; Humans; Hypolipidemic Agents; Lipid Metabolism; Lipids; Liver; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Multienzyme Complexes; Phenols; Phosphorylation; Polyphenols; Protein Serine-Threonine Kinases; Receptors, LDL; Resveratrol; Stilbenes | 2006 |
Effect of resveratrol, tyrosol and beta-sitosterol on oxidised low-density lipoprotein-stimulated oxidative stress, arachidonic acid release and prostaglandin E2 synthesis by RAW 264.7 macrophages.
Topics: Animals; Antioxidants; Arachidonic Acid; Atherosclerosis; Cells, Cultured; Dinoprostone; Hydrogen Peroxide; Lipid Metabolism; Lipoproteins, LDL; Macrophages; Mice; Olive Oil; Oxidative Stress; Phenylethyl Alcohol; Plant Oils; Protein Binding; Resveratrol; Sitosterols; Stilbenes; Wine | 2008 |